TE_196

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family L2
TE superfamily L2
TE class LINE
Gene CAPZB
Class Chimeric
Coding Non-coding, Other
Tumor-specific score 3.83
Counts of samples TCGA_tumor:410; TCGA_normal:45; GTEx:75
TSS chr1(-):19353613



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_196.1 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19344434,19345187,19345252,19353535,19353614
teRNA_196.2 CAPZB Chimeric Other MTRAWIRQPWEGQRGQPCSREMEKDETVSDCSPHIANIGRLVEDMENKIRSTLNEIYFGKTKDIVNGLRSIDAIPDNQKFKQLQRELSQVLTQRQIYIQPDN* chr1(-):19339597,19339617,19342752,19342864,19344358,19344434,19345187,19345252,19353535,19353614
teRNA_196.3 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19345252,19353535,19353614
teRNA_196.4 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19342752,19342864,19344358,19345252,19353535,19353614
teRNA_196.5 CAPZB Chimeric Non-coding Non-coding chr1(-):19342844,19342864,19344358,19344434,19345187,19345252,19353535,19353614
teRNA_196.6 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19342752,19342864,19344358,19344434,19353535,19353614
teRNA_196.7 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19344434,19345187,19345252,19352747,19352943,19353535,19353614
teRNA_196.8 CAPZB Chimeric Other MLPPPSPASIIFGFYFSHLQPPKDVSQGRQLEDKMEKDETVSDCSPHIANIGRLVEDMENKIRSTLNEIYFGKTKDIVNGLRSIDAIPDNQKFKQLQRELSQVLTQRQIYIQPDN* chr1(-):19339597,19339617,19342752,19342864,19344358,19344434,19345187,19345252,19352747,19352943,19353535,19353614
teRNA_196.9 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19345187,19345252,19352747,19352943,19353535,19353614
teRNA_196.10 CAPZB Chimeric Non-coding Non-coding chr1(-):19339597,19339617,19344358,19345252,19352747,19352943,19353535,19353614


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).